29.09.2024, 1741 Zeichen

Marinomed: Marinomed Biotech AG reported positive clinical data for the new moisturizing Carragelose-containing eye drops.  The results of the study show that treatment with Carragelose eye drops for four weeks significantly improves dry eye-related symptoms by 54%. Next to excellent tolerability, patients also reported a significant improvement in Ocular Surface. The eye drops are part of the recent Carragelose portfolio expansion from viral respiratory infections to targeting allergy and dry eyes. The clinical study conducted in Spain investigated for the first time the lubricating and hydrating effectiveness of Carragelose eye drops in patients affected by mild to moderate dry eye syndrome. 28 Patients were exposed to adverse environmental conditions (23°C, 10% relative humidity and airflow) to challenge dry eye symptoms. Treatment was started after the first challenge and lasted 28 days with a dose of one drop per eye, three times daily. After this treatment period, the patients were again exposed to adverse conditions and the effectiveness of the eye drops were assessed compared to the first challenge. The primary endpoint of the study was the improvement of dry eye-related symptoms such as foreign body sensation, burning or stinging, itching, pain, sticky feeling, sensitivity to light or blurred vision.
Marinomed Biotech: weekly performance: 6.76%

AT&S: AT&S CEO Andreas Gerstenmayer reached an agreement with the Nomination Committee to step down from the AT&S AG Executive Board on September 30, 2024. AT&S is a globally leading manufacturer of high-end IC substrates and printed circuit boards.
AT&S: weekly performance: 0.50%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (24/09/2024)

Christian Drastil: Wiener Börse Plausch

Börsenradio Live-Blick, Do. 31.10.24: DAX im Minus und die Jahresverlierer Sartorius, RWE, Brenntag, Bayer auf Low

Bildnachweis

Aktien auf dem Radar:Agrana, Pierer Mobility, Kapsch TrafficCom, Immofinanz, CA Immo, Flughafen Wien, Amag, Marinomed Biotech, VIG, voestalpine, Porr, Verbund, AT&S, EVN, Lenzing, Cleen Energy, FACC, Palfinger, Polytec Group, RBI, Telekom Austria, Warimpex, Zumtobel, Oberbank AG Stamm, Strabag, Austriacard Holdings AG, Erste Group, Österreichische Post, S Immo, Uniqa, Wienerberger.

---